These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8752252

  • 1. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia.
    Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML.
    Obstet Gynecol; 1996 Sep; 88(3):420-7. PubMed ID: 8752252
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia.
    Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML.
    Am J Obstet Gynecol; 1994 Jun; 170(6):1752-7; discussion 1757-9. PubMed ID: 8203436
    [Abstract] [Full Text] [Related]

  • 3. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia.
    Visser W, Beckmann I, Knook MA, Wallenburg HC.
    Acta Obstet Gynecol Scand; 2002 Aug; 81(8):713-9. PubMed ID: 12174154
    [Abstract] [Full Text] [Related]

  • 4. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?
    Greer IA, Lyall F, Perera T, Boswell F, Macara LM.
    Obstet Gynecol; 1994 Dec; 84(6):937-40. PubMed ID: 7526306
    [Abstract] [Full Text] [Related]

  • 5. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels.
    Livingston JC, Park V, Barton JR, Elfering S, Haddad B, Mabie WC, Quasney M, Sibai BM.
    Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201
    [Abstract] [Full Text] [Related]

  • 6. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR, Sanabria-Vera CJ, Romero-Adrián T.
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [Abstract] [Full Text] [Related]

  • 7. Soluble receptors for tumor necrosis factor: occurrence in association with normal delivery at term.
    Austgulen R, Johnsen H, Kjøllesdal AM, Liabakk NB, Espevik T.
    Obstet Gynecol; 1993 Sep; 82(3):343-7. PubMed ID: 8395036
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha is decreased in the umbilical cord plasma of patients with severe preeclampsia.
    Kupferminc MJ, Peaceman AM, Dollberg S, Socol ML.
    Am J Perinatol; 1999 Sep; 16(5):203-8. PubMed ID: 10535611
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of nonspecific immunity and plasma levels of interferon-gamma, interleukin-6 and tumor necrosis factor-alpha in preeclampsia.
    Munno I, Chiechi LM, Lacedra G, Berardesca C, Patimo C, Marcuccio L, Nardelli P, Loizzi P.
    Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):551-64. PubMed ID: 10466079
    [Abstract] [Full Text] [Related]

  • 10. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW, Park JS, Shim SS, Jun JK, Yoon BH, Romero R.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [Abstract] [Full Text] [Related]

  • 11. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K, Segami N, Sun W, Sato J, Fujimura K.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [Abstract] [Full Text] [Related]

  • 12. Persistency of high proinflammatory cytokine levels from colostrum to mature milk in preeclampsia.
    Erbağci AB, Cekmen MB, Balat O, Balat A, Aksoy F, Tarakçioğlu M.
    Clin Biochem; 2005 Aug; 38(8):712-6. PubMed ID: 15953598
    [Abstract] [Full Text] [Related]

  • 13. Feto-maternal bone remodeling in normal pregnancy and preeclampsia.
    Shaarawy M, Zaki S, Ramzi AM, Salem ME, El-Minawi AM.
    J Soc Gynecol Investig; 2005 Jul; 12(5):343-8. PubMed ID: 15979546
    [Abstract] [Full Text] [Related]

  • 14. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
    Himmerich H, Beitinger PA, Fulda S, Wehrle R, Linseisen J, Wolfram G, Himmerich S, Gedrich K, Wetter TC, Pollmächer T.
    Arch Intern Med; 2006 Sep 18; 166(16):1739-43. PubMed ID: 16983052
    [Abstract] [Full Text] [Related]

  • 15. Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro.
    Donker RB, Asgeirsdóttir SA, Gerbens F, van Pampus MG, Kallenberg CG, te Meerman GJ, Aarnoudse JG, Molema G.
    J Soc Gynecol Investig; 2005 Feb 18; 12(2):98-106. PubMed ID: 15695104
    [Abstract] [Full Text] [Related]

  • 16. Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies.
    Opsjøn SL, Novick D, Wathen NC, Cope AP, Wallach D, Aderka D.
    J Reprod Immunol; 1995 Jul 18; 29(2):119-34. PubMed ID: 7500319
    [Abstract] [Full Text] [Related]

  • 17. Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium.
    Omu AE, Al-Qattan F, Diejomaoh ME, Al-Yatama M.
    Acta Obstet Gynecol Scand; 1999 Sep 18; 78(8):675-80. PubMed ID: 10468058
    [Abstract] [Full Text] [Related]

  • 18. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
    Enquobahrie DA, Williams MA, Qiu C, Woelk GB, Mahomed K.
    J Matern Fetal Neonatal Med; 2005 May 18; 17(5):343-8. PubMed ID: 16147848
    [Abstract] [Full Text] [Related]

  • 19. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
    Barber MD, Fearon KC, Ross JA.
    Clin Sci (Lond); 1999 Jan 18; 96(1):83-7. PubMed ID: 9857110
    [Abstract] [Full Text] [Related]

  • 20. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
    Molvarec A, Jermendy A, Nagy B, Kovács M, Várkonyi T, Hupuczi P, Prohászka Z, Rigó J.
    Clin Chim Acta; 2008 Jun 18; 392(1-2):52-7. PubMed ID: 18396154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.